# Cryospray Ablation of Surgical Resection Specimens To Determine Safety And Histological Effect In The Lung

> **NCT00747773** · PHASE4 · COMPLETED · sponsor: **CSA Medical, Inc.** · enrollment: 21 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DEVICE:** CryoSpray Ablation System

## Key facts

- **NCT ID:** NCT00747773
- **Lead sponsor:** CSA Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-06
- **Final completion:** 2008-08
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00747773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00747773, "Cryospray Ablation of Surgical Resection Specimens To Determine Safety And Histological Effect In The Lung". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00747773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*